Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Epstein-Barr Virus, High-Risk Human Papillomavirus and Abnormal Cervical Cytology in a Prospective Cohort of African Female Sex Workers.

Cameron JE, Rositch AF, Vielot NA, Mugo NR, Kwatampora JKL, Waweru W, Gilliland AE, Hagensee ME, Smith JS.

Sex Transm Dis. 2018 Oct;45(10):666-672. doi: 10.1097/OLQ.0000000000000857.

PMID:
29664764
2.

Self-collected vaginal swabs for HPV screening: An exploratory study of rural Black Mississippi women.

Crosby RA, Hagensee ME, Fisher R, Stradtman LR, Collins T.

Prev Med Rep. 2016 Dec 23;7:227-231. doi: 10.1016/j.pmedr.2016.12.014. eCollection 2017 Sep.

3.

Human Papillomavirus Prevalence Is Associated With Socioeconomic Gradients Within a Medically Underserved Appalachian Region.

Ware SL, Crosby R, Fisher R, Hagensee ME.

Sex Transm Dis. 2017 Dec;44(12):750-755. doi: 10.1097/OLQ.0000000000000675.

PMID:
28876304
4.

Clinical Case Of the Month: A 35 Year Old Woman with Abdominal Pain.

Spera M, Thelin C, Gandolfi A, Clayton N, Nettles KM, Hagensee ME, Hutchings JJ, Lopez F.

J La State Med Soc. 2016 May-Jun;168(3):115-9. Epub 2016 Jun 15. Review.

PMID:
27389384
5.

Histological Evidence of Chronic Mycoplasma genitalium-Induced Cervicitis in HIV-Infected Women: A Retrospective Cohort Study.

Dehon PM, Hagensee ME, Sutton KJ, Oddo HE, Nelson N, McGowin CL.

J Infect Dis. 2016 Jun 1;213(11):1828-35. doi: 10.1093/infdis/jiw025. Epub 2016 Jan 17.

6.

Community-Based Screening for Cervical Cancer: A Feasibility Study of Rural Appalachian Women.

Crosby RA, Hagensee ME, Vanderpool R, Nelson N, Parrish A, Collins T, Jones N.

Sex Transm Dis. 2015 Nov;42(11):607-11. doi: 10.1097/OLQ.0000000000000365.

7.

Epidemiologic factors associated with seropositivity to human papillomavirus type 16 and 18 virus-like particles and risk of subsequent infection in men.

Lu B, Hagensee ME, Lee JH, Wu Y, Stockwell HG, Nielson CM, Abrahamsen M, Papenfuss M, Harris RB, Giuliano AR.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):511-6. doi: 10.1158/1055-9965.EPI-09-0790. Epub 2010 Jan 19.

8.

HPV 6/11, 16, 18 seroprevalence in men in two US cities.

Dunne EF, Nielson CM, Hagensee ME, Papenfuss MR, Harris RB, Herrel N, Gourlie J, Abrahamsen M, Markowitz LE, Giuliano AR.

Sex Transm Dis. 2009 Nov;36(11):671-4. doi: 10.1097/OLQ.0b013e3181bc094b.

PMID:
19809385
9.

Development and validation of a HPV-32 specific PCR assay.

Herrel NR, Johnson NL, Cameron JE, Leigh J, Hagensee ME.

Virol J. 2009 Jun 27;6:90. doi: 10.1186/1743-422X-6-90.

10.

Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding.

Kissinger P, Amedee A, Clark RA, Dumestre J, Theall KP, Myers L, Hagensee ME, Farley TA, Martin DH.

Sex Transm Dis. 2009 Jan;36(1):11-6. doi: 10.1097/OLQ.0b013e318186decf.

11.

Oral HPV complications in HIV-infected patients.

Cameron JE, Hagensee ME.

Curr HIV/AIDS Rep. 2008 Aug;5(3):126-31. Review.

PMID:
18627661
12.

Knowledge of Pap screening and human papillomavirus among women attending clinics in Medellín, Colombia.

Hanisch R, Gustat J, Hagensee ME, Baena A, Salazar JE, Castro MV, Gaviria AM, Sánchez GI.

Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1020-6. Epub 2007 Nov 16.

PMID:
18021221
13.

Human papillomavirus infection and disease in the HIV+ individual.

Cameron JE, Hagensee ME.

Cancer Treat Res. 2007;133:185-213. Review.

PMID:
17672042
14.

The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults.

Cameron JE, Mercante D, O'Brien M, Gaffga AM, Leigh JE, Fidel PL Jr, Hagensee ME.

Sex Transm Dis. 2005 Nov;32(11):703-9.

PMID:
16254546
15.

Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections.

Chaturvedi AK, Myers L, Hammons AF, Clark RA, Dunlap K, Kissinger PJ, Hagensee ME.

Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2439-45.

16.

The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanisms.

Bolt J, Vo QN, Kim WJ, McWhorter AJ, Thomson J, Hagensee ME, Friedlander P, Brown KD, Gilbert J.

Oral Oncol. 2005 Nov;41(10):1013-20. Epub 2005 Aug 31.

PMID:
16139561
17.

Lack of evidence for local immune activity in oral hairy leukoplakia and oral wart lesions.

Lilly EA, Cameron JE, Shetty KV, Leigh JE, Hager S, McNulty KM, Cheeks C, Hagensee ME, Fidel PL Jr.

Oral Microbiol Immunol. 2005 Jun;20(3):154-62.

PMID:
15836516
18.

Vaginal swabs versus lavage for detection of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women.

Kissinger PJ, Dumestre J, Clark RA, Wenthold L, Mohammed H, Hagensee ME, Martin DH.

Sex Transm Dis. 2005 Apr;32(4):227-30.

PMID:
15788920
19.

Prevalence of human papillomavirus genotypes in women from three clinical settings.

Chaturvedi AK, Dumestre J, Gaffga AM, Mire KM, Clark RA, Braly PS, Dunlap K, Beckel TE, Hammons AF, Kissinger PJ, Hagensee ME.

J Med Virol. 2005 Jan;75(1):105-13.

PMID:
15543579
20.

Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States.

Thompson DL, Douglas JM Jr, Foster M, Hagensee ME, Diguiseppi C, Barón AE, Cameron JE, Spencer TC, Zenilman J, Malotte CK, Bolan G, Kamb ML, Peterman TA; Project RESPECT Study Group.

J Infect Dis. 2004 Nov 1;190(9):1563-74. Epub 2004 Sep 23.

PMID:
15478060
21.

Human papillomavirus infection and disease in HIV-infected individuals.

Hagensee ME, Cameron JE, Leigh JE, Clark RA.

Am J Med Sci. 2004 Jul;328(1):57-63. Review.

PMID:
15254442
22.

Distribution of human papillomavirus type 16 variants in human immunodeficiency virus type 1-positive and -negative women.

Chaturvedi AK, Brinkman JA, Gaffga AM, Dumestre J, Clark RA, Braly PS, Dunlap K, Kissinger PJ, Hagensee ME.

J Gen Virol. 2004 May;85(Pt 5):1237-41.

PMID:
15105540
23.

Optimization of PCR based detection of human papillomavirus DNA from urine specimens.

Brinkman JA, Rahmani MZ, Jones WE, Chaturvedi AK, Hagensee ME.

J Clin Virol. 2004 Apr;29(4):230-40.

PMID:
15018850
24.

Detection of human papillomavirus DNA in self-administered vaginal swabs as compared to cervical swabs.

Palmisano ME, Gaffga AM, Daigle J, Brinkman J, Mire K, Lenczyk K, Martin DH, Hagensee ME.

Int J STD AIDS. 2003 Aug;14(8):560-7.

PMID:
12935387
25.
26.

Detection of human papillomavirus DNA in urine specimens from human immunodeficiency virus-positive women.

Brinkman JA, Jones WE, Gaffga AM, Sanders JA, Chaturvedi AK, Slavinsky III J, Clayton JL, Dumestre J, Hagensee ME.

J Clin Microbiol. 2002 Sep;40(9):3155-61.

27.

Comparative analysis of methods for collection and measurement of cytokines and immunoglobulins in cervical and vaginal secretions of HIV and HPV infected women.

Snowhite IV, Jones WE, Dumestre J, Dunlap K, Braly PS, Hagensee ME.

J Immunol Methods. 2002 May 1;263(1-2):85-95.

PMID:
12009206
28.

Seroepidemiology of low and high oncogenic risk types of human papillomavirus in a predominantly male cohort of STD clinic patients.

Slavinsky J 3rd, Kissinger P, Burger L, Boley A, DiCarlo RP, Hagensee ME.

Int J STD AIDS. 2001 Aug;12(8):516-23.

PMID:
11487392
29.

Infection with Human Papillomavirus: Update on Epidemiology, Diagnosis, and Treatment.

Hagensee ME.

Curr Infect Dis Rep. 2000 Feb;2(1):18-24.

PMID:
11095833
30.

Detection of cervical antibodies to human papillomavirus type 16 (HPV-16) capsid antigens in relation to detection of HPV-16 DNA and cervical lesions.

Hagensee ME, Koutsky LA, Lee SK, Grubert T, Kuypers J, Kiviat NB, Galloway DA.

J Infect Dis. 2000 Apr;181(4):1234-9. Epub 2000 Apr 7.

PMID:
10753726
31.

Seroprevalence of human papillomavirus type 16 in pregnant women.

Hagensee ME, Slavinsky J 3rd, Gaffga CM, Suros J, Kissinger P, Martin DH.

Obstet Gynecol. 1999 Nov;94(5 Pt 1):653-8.

PMID:
10546705
32.

Cofactors with human papillomavirus in a population-based study of vulvar cancer.

Madeleine MM, Daling JR, Carter JJ, Wipf GC, Schwartz SM, McKnight B, Kurman RJ, Beckmann AM, Hagensee ME, Galloway DA.

J Natl Cancer Inst. 1997 Oct 15;89(20):1516-23. Erratum in: J Natl Cancer Inst 1997 Dec 17;89(24):1896.

PMID:
9337348
33.

Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men.

Hagensee ME, Kiviat N, Critchlow CW, Hawes SE, Kuypers J, Holte S, Galloway DA.

J Infect Dis. 1997 Sep;176(3):625-31.

PMID:
9291307
34.

The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.

Daling JR, Madeleine MM, McKnight B, Carter JJ, Wipf GC, Ashley R, Schwartz SM, Beckmann AM, Hagensee ME, Mandelson MT, Galloway DA.

Cancer Epidemiol Biomarkers Prev. 1996 Jul;5(7):541-8.

35.

Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts.

Carter JJ, Wipf GC, Hagensee ME, McKnight B, Habel LA, Lee SK, Kuypers J, Kiviat N, Daling JR, Koutsky LA, et al.

J Infect Dis. 1995 Jul;172(1):11-8.

PMID:
7797899
36.

Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies.

Hagensee ME, Carter JJ, Wipf GC, Galloway DA.

Virology. 1995 Jan 10;206(1):174-82.

37.

Mycotic aortic aneurysm due to Yersinia enterocolitica.

Hagensee ME.

Clin Infect Dis. 1994 Oct;19(4):801-2. No abstract available.

PMID:
7803661
38.

Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992.

Hagensee ME, Bauwens JE, Kjos B, Bowden RA.

Clin Infect Dis. 1994 Sep;19(3):402-8.

PMID:
7811856
39.

Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids.

Hagensee ME, Olson NH, Baker TS, Galloway DA.

J Virol. 1994 Jul;68(7):4503-5.

40.

Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a patient with GVHD after allogeneic BMT.

Hagensee ME, Benyunes M, Miller JA, Spach DH.

Bone Marrow Transplant. 1994 Mar;13(3):349-51.

PMID:
8199580
42.

Hyperthyroidism induced by iodinated glycerol.

Huseby JS, Bennett SW, Hagensee ME.

Am Rev Respir Dis. 1991 Dec;144(6):1403.

PMID:
1741556
43.

Bleomycin-treated DNA is specifically cleaved only by endonuclease IV in E. coli.

Hagensee ME, Moses RE.

Biochim Biophys Acta. 1990 Jan 30;1048(1):19-23.

PMID:
1688711
44.
45.
46.

DNA polymerase III of Escherichia coli is required for UV and ethyl methanesulfonate mutagenesis.

Hagensee ME, Timme TL, Bryan SK, Moses RE.

Proc Natl Acad Sci U S A. 1987 Jun;84(12):4195-9.

47.

Repair response of Escherichia coli to hydrogen peroxide DNA damage.

Hagensee ME, Moses RE.

J Bacteriol. 1986 Dec;168(3):1059-65.

Supplemental Content

Loading ...
Support Center